These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2329853)

  • 21. [Levels of plasma 1,25-dihydroxyvitamin D and parameters of phospho-calcium metabolism in children with non-dialyzed chronic renal failure].
    Loras B; Parchoux B; Durr F
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():755-60. PubMed ID: 6897703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Myopathy in uremic patients].
    Montagnac R; Shillinger F; Billaud B; Monvoisin G
    Rev Rhum Mal Osteoartic; 1990 Mar; 57(3):201-5. PubMed ID: 2187233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the inspiratory muscle weakness in functional capacity in hemodialysis patients.
    Figueiredo PH; Lima MM; Costa HS; Gomes RT; Neves CD; Oliveira ES; Alves FL; Rodrigues VG; Maciel EH; Balthazar CH
    PLoS One; 2017; 12(3):e0173159. PubMed ID: 28278163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of parathyroidectomy on respiratory muscle strength in uremic myopathy.
    Gómez-Fernández P; Sanchez Agudo L; Miguel JL; Almaraz M; Vila Dupla MJ
    Am J Nephrol; 1987; 7(6):466-9. PubMed ID: 3439556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is 1,25-dihydroxy-cholecalciferol harmful to renal function in patients with chronic renal failure?
    Christiansen C; Rødbro P; Christensen MS; Hartnack B
    Clin Endocrinol (Oxf); 1981 Sep; 15(3):229-36. PubMed ID: 6273027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Uremic myopathy in chronic kidney failure with dialysis].
    Ogura Y; Arizono K
    Nihon Rinsho; 1992 Jan; 50 Suppl():828-9. PubMed ID: 1533695
    [No Abstract]   [Full Text] [Related]  

  • 27. 1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial.
    Baker LR; Abrams L; Roe CJ; Faugere MC; Fanti P; Subayti Y; Malluche HH
    Kidney Int; 1989 Feb; 35(2):661-9. PubMed ID: 2651758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered.
    Dekhuijzen PN; Decramer M
    Eur Respir J; 1992 Sep; 5(8):997-1003. PubMed ID: 1426209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Respiratory muscle hypotonia as one of the causes of hypoventilation and hypoxemia in patients with chronic renal failure treated by hemodialysis].
    Wanic-Kossowska M
    Pol Arch Med Wewn; 1991 Jul; 86(1):26-30. PubMed ID: 1838411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypophosphatemia-associated respiratory muscle weakness in a general inpatient population.
    Gravelyn TR; Brophy N; Siegert C; Peters-Golden M
    Am J Med; 1988 May; 84(5):870-6. PubMed ID: 3364446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electromyographic study of muscular weakness in chronic renal failure.
    Isaacs H
    S Afr Med J; 1969 May; 43(22):683-8. PubMed ID: 5786234
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of skeletal muscle function during calcitriol treatment in patients dialyzed for uremia].
    Wanic-Kossowska M; Bombicki K; Płotast H; Grzegorzewska A
    Pol Arch Med Wewn; 1996 Jan; 95(1):41-52. PubMed ID: 8677194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma.
    Decramer M; Stas KJ
    Am Rev Respir Dis; 1992 Sep; 146(3):800-2. PubMed ID: 1519868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral dose.
    Papapoulos SE; Clemens TL; Sandler LM; Fraher LJ; Winer J; O'Riordan JL
    Clin Sci (Lond); 1982 Apr; 62(4):427-9. PubMed ID: 6896025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticosteroid-induced myopathy and the respiratory muscles. Report of two cases.
    Janssens S; Decramer M
    Chest; 1989 May; 95(5):1160-2. PubMed ID: 2707077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 1,25(OH)2D3 administration on bone in patients with renal failure.
    Malluche HH; Faugere MC
    Kidney Int Suppl; 1990 Sep; 29():S48-53. PubMed ID: 2214547
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of potassium in muscle membrane dysfunction in end-stage renal disease.
    Larsen LH; Z'Graggen WJ; Bostock H; Tan SV; Buus NH; Tankisi H
    Clin Neurophysiol; 2021 Dec; 132(12):3125-3135. PubMed ID: 34740043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myopathy of uremia.
    Ritz E; Kreusser W; Rambausek M; Mehls O
    Adv Exp Med Biol; 1984; 178():377-86. PubMed ID: 6507166
    [No Abstract]   [Full Text] [Related]  

  • 39. Prescription of calcium carbonate to nondialyzed patients with a supranormal serum 1,25(OH)2D3 concentration.
    Okada K; Takahashi S; Nagura Y; Hatano M
    Nephron; 1991; 59(4):683-4. PubMed ID: 1766521
    [No Abstract]   [Full Text] [Related]  

  • 40. Steroid myopathy in cancer patients.
    Batchelor TT; Taylor LP; Thaler HT; Posner JB; DeAngelis LM
    Neurology; 1997 May; 48(5):1234-8. PubMed ID: 9153449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.